REVA to Present at Citi 2012 Global Healthcare and ASX Small to Mid Caps Conferences
February 22 2012 - 7:44PM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased
to announce that its Chairman and CEO, Robert Stockman, is
scheduled to present at the Citi 2012 Global Healthcare Conference
at 9:00 a.m. US EST on Monday, February 27, 2012. The conference is
being held February 27 through 29, 2012 at The Waldorf Astoria
Hotel in New York.
Mr. Stockman will also present at the ASX Small to Mid Caps
Conference at 8:50 a.m. US EST on Thursday, March 1, 2012. The ASX
conference is being held at the Sofitel Hotel in New York.
The information in these presentations has been previously
disclosed. Copies of REVA's public presentations, which include
recent disclosures, may be accessed under the Investor Relations
section of the REVA website at www.revamedical.com.
About REVA
REVA is a development stage medical device company incorporated
in Delaware, USA, that is focused on the development and eventual
commercialisation of its proprietary, bioresorbable stent products.
REVA's lead product, the ReZolve™ scaffold, combines REVA's
proprietary stent design with a proprietary polymer that is
metabolized and cleared from the body. The ReZolve scaffold is
designed to offer full x-ray visibility, clinically relevant sizing
and a controlled and safe resorption rate. In addition, by early
encapsulation of the stent in the artery tissue coupled with the
loss of scaffold structure over time, the ReZolve scaffold may
reduce the incidence of late forming blood clots, or thrombosis, a
rare but serious problem associated with drug-eluting metal stents
currently on the market. REVA will require clinical results and
regulatory approval before it can begin selling the ReZolve
scaffold.
The REVA Medical, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8505
CONTACT: United States
Investor and Media Enquiries:
Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045
Australia
Investor Enquiries:
David Allen or Alan Taylor
Inteq Limited
+61 2 9231 3322
Media Enquiries:
Katie Mackenzie or Rebecca Wilson
Buchan Consulting
+61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Reva Medical (ASX:RVA)
Historical Stock Chart
From Apr 2023 to Apr 2024